Summary

Prohibits the Department of Health and Human Services (HHS) from declaring or continuing any public health emergency related to abortion and ends any such emergency in effect when the law takes effect. Requires HHS and the FDA to enforce and reinstate a Risk Evaluation and Mitigation Strategy (REMS) that limits abortion drugs to in-person dispensing at clinics, medical offices, or hospitals under a certified provider’s supervision. Also bars HHS/FDA from loosening REMS protections for abortion drugs until every state submits standardized, aggregate abortion data to the CDC’s surveillance system; it makes those data fields mandatory for the purposes of a related Medicaid reporting provision. The bill defines key terms (including “abortion,” “abortion drug,” and “certified health care provider”) and makes the in-person dispensing and emergency restrictions effective on enactment.

Key Points

• Bars HHS from declaring or using public health emergency powers for abortion and ends any such current declaration on enactment.
• Requires FDA/HHS to reinstate and enforce a REMS that mandates in-person dispensing of abortion drugs at clinics, medical offices, or hospitals under provider supervision.
• Prevents loosening REMS protections until every state submits standardized, aggregate abortion data to the CDC surveillance system.
• Designates the required CDC worksheet fields as mandatory questions under a Social Security Act provision tied to Medicaid reporting.
• Defines terms such as "abortion," "abortion drug," "certified health care provider," and "unborn child."
• Makes the in-person dispensing and emergency-declaration prohibitions effective immediately on enactment.
• Does not provide new funding or change tax or appropriation law; focuses on regulatory restrictions and data reporting conditions.

Categories & Tags